Markel Co. (NYSE:MKL) – Equities research analysts at William Blair issued their Q2 2019 earnings estimates for shares of Markel in a report released on Monday. William Blair analyst A. Klauber forecasts that the insurance provider will post earnings of $8.84 per share for the quarter. William Blair has a “Outperform” rating on the stock. William Blair also issued estimates for Markel’s Q3 2019 earnings at $9.30 EPS.
MKL has been the topic of a number of other research reports. Zacks Investment Research upgraded shares of Markel from a “hold” rating to a “buy” rating and set a $1,253.00 target price on the stock in a research report on Friday, January 5th. Royal Bank of Canada restated a “hold” rating and set a $1,200.00 target price on shares of Markel in a research report on Thursday, February 8th. ValuEngine lowered shares of Markel from a “hold” rating to a “sell” rating in a research report on Thursday, March 1st. Finally, SunTrust Banks upped their price target on shares of Markel to $1,200.00 and gave the stock a “hold” rating in a report on Thursday, February 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $1,172.00.
Shares of MKL stock traded up $4.40 during trading hours on Wednesday, hitting $1,160.00. 15,435 shares of the company’s stock were exchanged, compared to its average volume of 34,900. Markel has a 1 year low of $936.95 and a 1 year high of $1,194.98. The firm has a market cap of $16,266.83, a price-to-earnings ratio of 45.05 and a beta of 0.95. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.60 and a current ratio of 0.60.
Markel (NYSE:MKL) last announced its earnings results on Tuesday, February 6th. The insurance provider reported $6.64 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $8.55 by ($1.91). Markel had a return on equity of 0.39% and a net margin of 6.52%. The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.58 billion.
In other news, insider Alan I. Kirshner sold 100 shares of the company’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $1,133.50, for a total transaction of $113,350.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Richard R. Whitt III sold 300 shares of the company’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $1,060.02, for a total transaction of $318,006.00. Following the sale, the chief executive officer now directly owns 9,652 shares of the company’s stock, valued at approximately $10,231,313.04. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,800 shares of company stock valued at $2,001,120. 2.53% of the stock is currently owned by insiders.
Institutional investors have recently modified their holdings of the company. Aevitas Wealth Management Inc. bought a new stake in shares of Markel during the 4th quarter worth approximately $108,000. First Personal Financial Services lifted its holdings in shares of Markel by 156.1% during the 4th quarter. First Personal Financial Services now owns 105 shares of the insurance provider’s stock worth $120,000 after acquiring an additional 64 shares during the period. SeaCrest Wealth Management LLC bought a new stake in shares of Markel during the 4th quarter worth approximately $122,000. Simplex Trading LLC lifted its holdings in shares of Markel by 169.1% during the 4th quarter. Simplex Trading LLC now owns 148 shares of the insurance provider’s stock worth $168,000 after acquiring an additional 93 shares during the period. Finally, Cigna Investments Inc. New bought a new stake in shares of Markel during the 4th quarter worth approximately $201,000. 78.12% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This article was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/03/23/brokers-offer-predictions-for-markel-co-s-q2-2019-earnings-mkl.html.
Markel Company Profile
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.